Browsing: medication

Bial has proudly launched KYNMOBI® (Apomorphine Hydrochloride) in the United Kingdom, offering a groundbreaking new treatment for patients with Parkinson’s disease experiencing OFF episodes. This thrilling introduction marks a significant milestone in broadening Bial’s innovative portfolio

New research reveals the surprising and complex ways acetaminophen works, extending well beyond just relieving pain and reducing fever. These groundbreaking findings have the potential to revolutionize future treatments and reshape safety standards